Literature DB >> 20646184

The presentation of hypoactive sexual desire disorder in premenopausal women.

Nancy N Maserejian1, Jan L Shifren, Sharon J Parish, Glenn D Braunstein, Eric P Gerstenberger, Raymond C Rosen.   

Abstract

INTRODUCTION: Little is known about the clinical presentation of hypoactive sexual desire disorder (HSDD) in premenopausal women or their perceptions of sexual problems. AIM: Describe characteristics of premenopausal women with clinically diagnosed acquired, generalized HSDD, and investigate factors perceived to contribute to desire problems.
METHODS: Cross-sectional analysis of baseline data from premenopausal women with clinically diagnosed and confirmed HSDD enrolled during the first year of the HSDD Registry for Women (N=400). MAIN OUTCOME MEASURES: Relationship, demographic, and clinical characteristics were assessed by clinician's medical history review and self-administered questionnaire. Sexual desire function was measured by the validated Female Sexual Function Index (FSFI).
RESULTS: Over 85% of women cited multiple factors that contributed to ongoing decreased desire (mean 2.9± 2.3 factors, range 0-12). Most commonly cited contributing factors were "stress or fatigue" (60.0%), "dissatisfaction with my physical appearance" (40.8%), and other sexual difficulties (e.g., inability to reach orgasm) (33.5%). Exploratory analyses of the FSFI score confirmed that self-image (P=0.002) and other sexual problems (P<0.001) were significantly associated with decreased desire. Almost all (96%) participants were currently in a partner relationship. Antidepressant medication was currently used by 18.0% of women, hormonal contraceptives by 28.5%, and hormonal medications (for noncontraceptive reasons) by 7.3%. Physical functioning was consistent with general population norms (SF-36 mean±standard deviation, 53.3±7.6 vs. norm of 50±10), while overall mental functioning was slightly lower (SF-36, 44.7±10.6).
CONCLUSIONS: Within this sample of premenopausal women with clinically diagnosed HSDD, decreased sexual desire was associated with multiple factors, including poor self-image and stress or fatigue. Clinicians presented with premenopausal women expressing sexual desire problems should assess patients' perceptions of their condition to develop a comprehensive, patient-oriented management plan. Therapy may need to address issues with low self-esteem and mood and offer practical coping mechanisms for stress and fatigue.
© 2010 International Society for Sexual Medicine.

Entities:  

Mesh:

Year:  2010        PMID: 20646184     DOI: 10.1111/j.1743-6109.2010.01934.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  3 in total

1.  Sexual Dysfunction in Women With Migraine and Overweight/Obesity: Relative Frequency and Association With Migraine Severity.

Authors:  Dale S Bond; Jelena M Pavlović; Richard B Lipton; J Graham Thomas; Kathleen B Digre; Julie Roth; Lucille Rathier; Kevin C O'Leary; E Whitney Evans; Rena R Wing
Journal:  Headache       Date:  2016-12-28       Impact factor: 5.887

2.  Body Image and Hypoactive Sexual Desire Disorder Relationship in a Representative Sample of Iranian Women.

Authors:  Zeinab Hamzehgardeshi; Mina Malary; Mahmood Moosazadeh; Soghra Khani; Mehdi Pourasghar
Journal:  J Family Reprod Health       Date:  2020-06

3.  Next-day residual effects of flibanserin on simulated driving performance in premenopausal women.

Authors:  Gary G Kay; Thomas Hochadel; Eric Sicard; Karthi K Natarajan; Noel N Kim
Journal:  Hum Psychopharmacol       Date:  2017-05-31       Impact factor: 1.672

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.